Reuters Health Report

Click to View in Browser 02/21/2014 E-cig industry on tenterhooks ahead of U.S. regulation WASHINGTON (Reuters) - Lobbyists for electronic cigarette companies have been beating a path to the White House, hoping to prevent the administration from imposing strict, and possibly costly, rules on the burgeoning $2 billion industry. EU Agency backs respiratory drugs for approval LONDON (Reuters) - European regulators recommended the approval of a clutch of drugs to treat respiratory diseases on Friday, including two from GlaxoSmithKline and another from Teva Pharmaceuticals. Flu activity highest among U.S. young and middle-aged: CDC ATLANTA (Reuters) - Hardest hit this U.S. flu season are adults, from younger to middle-aged, in part because fewer have been vaccinated, a federal health agency said on Thursday as the season enters its final weeks. Marriage Quality May Influence Heart Disease Risk NEW YORK (Reuters Health) - Ambivalent hearts may be at higher risk for heart disease, according to a new study of married couples with mixed feelings for one another. At-Home Exercise Helps After Hip Break: study NEW YORK (Reuters Health) - Simple at-home exercises could help seniors regain mobility and independence after recovering from a broken hip, according to a new study. Testosterone therapy for "low T" carries risk: endocrinologists NEW YORK (Reuters Health) - Older men considering taking testosterone for low libido, fatigue, irritability or muscle loss should be made aware of the heart-related risks of testosterone therapy, according to a statement from the Endocrine Society. Life-Jacket Laws Spur Use, Could Prevent Drownings NEW YORK (Reuters Health) - Dr. Linda Quan lost count of the number of children she watched slowly die from drowning. But she will never forget the pain on the faces of her patients' parents when she broke the news to them. GlaxoSmithKline's COPD drug Anoro receives European green light LONDON (Reuters) - Anoro, a combination drug for chronic obstructive pulmonary disease (COPD) developed by GlaxoSmithKline and Theravance, has received the green light from European regulators, the companies said on Thursday. Raptor says Huntington's disease drug slows loss of muscle control (Reuters) - Raptor Pharmaceutical Corp said its experimental brain disorder drug slowed the loss of muscle control in patients with Huntington's disease after 18 months of treatment. Nepal must toughen fight on women's "fallen womb" crisis -Amnesty KATHMANDU, Feb 20 (Thomson Reuters Foundation) - When pregnant Nepali teenager Reena Pokharel began labor in her remote village, her family consulted a soothsayer, pressed her stomach and told her to cough to force the baby out. Related Video Beijing issues pollution alert for three days of smog Vienna study gives voice to elephant rumblings The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend